340B News & Regulatory Updates — October 2026

The Most Important 340B Developments of October 2026

Published by 340bprogram.com | October 31, 2026
Sources: HRSA Office of Pharmacy Affairs, CMS, AHA, Supreme Court of the United States, Healthcare Finance News, Pharmaceutical Commerce, Health & Life Sciences News, 340B Report, Benesch, Mintz, Arkansas Attorney General, America’s Essential Hospitals



OCTOBER 2026 OVERVIEW

October turned the rebate pilot into a three-front fight: HRSA approved the manufacturers, hospitals sued again, and a House bill proposed a two-year delay. The full Fourth Circuit also heard the state contract pharmacy cases.

  • October 1: HRSA posted ten approved manufacturer rebate plans, all starting January 1, 2027 and all using the Beacon platform. The manufacturers are AbbVie, Amgen, Astellas, AstraZeneca, Boehringer Ingelheim, Bristol Myers Squibb, GSK, Merck, Pfizer and Teva. HRSA · Benesch
  • October 1: CMS opened its Medicare Part D 340B claims data repository for voluntary submissions. CMS has proposed making submissions mandatory for claims on or after January 1, 2027. Voluntary data for January–September 2026 claims is requested by December 31, 2026. AHA · CMS fact sheet (PDF)
  • October 1–15: HRSA’s quarterly OPAIS registration window, for contract pharmacy arrangements starting January 1, 2027. HRSA registration
  • October 2: Novartis asked the Supreme Court to review the Fifth Circuit’s ruling upholding Mississippi’s contract pharmacy law (No. 26-457). Mississippi’s response was due November 6. Supreme Court docket
  • About October 3: Approved manufacturers’ 90-day notices to covered entities came due for a January 1 start. Mintz
  • October 9: The American Hospital Association, the Maine Hospital Association and four safety-net hospitals sued in federal court in Maine to block the revised pilot and asked for a temporary restraining order. They estimate the pilot would cost 340B hospitals more than $1 billion a year. Healthcare Finance News · Pharmaceutical Commerce
  • Mid-October: Representatives Rob Bresnahan, Debbie Dingell, Tracey Mann and Lois Frankel introduced the 340B Rebate Model Delay Act (H.R. 10770). It would keep upfront 340B discounts through December 31, 2028 and bar federal funds for the pilot. AHA endorsed it on October 15. Benesch · AHA
  • October 21–26: Drug manufacturers and PhRMA sought to join the Maine case to defend the pilot. AHA opposed, and weekly docket reports say the court granted a motion to intervene. As of month end, no ruling on blocking the pilot had been reported. AHA · Health & Life Sciences News
  • October 27: The full Fourth Circuit heard argument on West Virginia’s and Maryland’s contract pharmacy laws. Reporters described the judges as sharply divided. No decision yet. 340B Report
  • During the month: Drugmakers moved Arkansas’s state-court suit over Act 1103 into federal court. Attorney General Tim Griffin filed that suit in July against 13 manufacturers and data vendor Second Sight Solutions. 340B Report · Arkansas AG
  • Just after month end (November 4): CMS finalized the 2027 Medicare outpatient rule, paying 340B hospitals ASP minus 28% for 340B drugs instead of the proposed ASP minus 33.4%. Critical access hospitals, rural sole community hospitals and children’s hospitals are exempt. America’s Essential Hospitals · CMS fact sheet

What it means for independent pharmacies: Plan for the rebate pilot to start January 1 unless a court or Congress stops it. Ask each covered-entity partner whether they received manufacturers’ 90-day notices and how your claims data will reach Beacon. Hospital partners now face lower Medicare payment on 340B drugs in 2027, so expect closer review of contract pharmacy fees.

What to watch in Q4 2026

When

What

Why it matters to a contract pharmacy

October 1–15

HRSA’s quarterly OPAIS registration window

Contract pharmacy arrangements registered now can start January 1, 2027

Early October

Manufacturers’ 90-day notices for the rebate pilot

Covered entities learn each manufacturer’s data and ordering instructions

October 2

Novartis’s extended deadline to seek Supreme Court review of the Mississippi ruling

A petition would put state contract pharmacy laws before the Court

November (CMS’s usual timing)

Final 2027 Medicare outpatient rule

Decides whether the ASP minus 33.4% hospital payment cut takes effect

No date set

En banc Fourth Circuit decision on West Virginia and Maryland

Decides whether a circuit split on state laws exists

January 1, 2027

Rebate pilot begins for 21 drugs

Partners pay full price up front and need clean claims data from you

The American Hospital Association said after the approvals that it is weighing its options to stop the pilot, so a new court challenge is possible. Becker’s

Sources

Every item above links to the page it came from. These are the primary sources and trackers worth bookmarking for future monthly updates:

Several summaries rely on law-firm and trade-association write-ups of court rulings. Read the linked opinion or notice before acting on any item, and have counsel review anything that affects a contract.



Information in this update is provided for general educational purposes by 340bprogram.com, published by Medication Packaging Solutions LLC. Sources include HRSA, U.S. federal courts, Forvis Mazars, Feldesman Tucker, Quarles Law, HFMA, and other publicly available resources. This is not legal or compliance advice. For compliance-specific guidance, consult a qualified 340B compliance consultant or healthcare attorney. Published: November, 2026.

340B Rebate Model Pilot, HRSA, Rebate Pilot Lawsuit, AHA v. Kennedy, 340B Rebate Model Delay Act, H.R. 10770, CMS 340B Repository, Medicare Part D, Fourth Circuit, West Virginia, Maryland, Supreme Court, Mississippi, Novartis, Arkansas, State Contract Pharmacy Laws, OPAIS Registration, OPPS 2027, Contract Pharmacy, Independent Pharmacy, October 2026Tags

Related articles